Qiagen introduces EZ2 Connect platform

By The Science Advisory Board staff writers

April 30, 2021 -- Qiagen has announced the upcoming launch of the EZ2 Connect product line, an automated sample-processing platform that aims to benefit biomedical research, forensics, and clinical diagnostics.

EZ2 Connect instruments use prefilled cartridges and magnetic bead technology to process up to 24 samples in parallel in as little as 20 minutes, ensuring process safety and efficiency of nucleic acid extraction. The new platform builds on Qiagen's EZ1 instrument line, which saw more than 4,500 devices installed worldwide at the end of 2020.

The EZ2 Connect platform will be tailored to three different key versions. The EZ2 Connect for use in research and pharmaceutical laboratory and the EZ2 Connect Fx for use in forensics and human identification will be launched in July. The release of the EZ2 Connect MDx for use in molecular diagnostic workflows is planned for early 2022, with regulatory approval in the U.S., the EU, and other markets worldwide.

Qiagen sales, earnings climb in Q3
Significant ongoing demand for COVID-19 testing and improved trends in other areas of Qiagen's product portfolio led to a 26% increase in preliminary...
Qiagen expands genomic tools for COVID-19 research
Qiagen launched a SARS-CoV-2 primer panel that converts viral RNA samples into libraries that are ready for next-generation sequencing of the novel coronavirus...
Thermo Fisher's acquisition of Qiagen falls short
Thermo Fisher Scientific has terminated its acquisition of Qiagen after the company was unable to secure the number of shares needed to proceed with the...

Copyright © 2021 scienceboard.net


Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter